What drove ALDEI.PA stock to be most active today?

A surge to **13,014,939** shares traded, more than double average, drove ALDEI.PA stock intraday activity. Micro-cap biotech moves often reflect speculative flows, news or positioning around clinical or partnership updates.

What is Meyka AI's grade for ALDEI.PA stock and what does it mean?

Meyka AI rates ALDEI.PA with a score of **64.81/100 (Grade B, HOLD)**. The grade combines benchmark, sector, financial growth, key metrics, forecasts and analyst consensus. It is informational and not financial advice.

What price targets and forecast does Meyka AI provide for ALDEI.PA stock?

Meyka AI's forecast model projects **€0.05** in 12 months (≈**88.68%** upside vs **€0.0265**). A base target **€0.04** and bullish **€0.10** can frame scenarios. Forecasts are model-based projections, not guarantees.

How risky is trading ALDEI.PA stock intraday?

Trading ALDEI.PA stock intraday is high risk due to low market cap (**€1,134,989.00**), volatile price swings, and limited liquidity at small absolute price levels. Use strict position sizing and expect slippage.

EU Stocks

ALDEI.PA stock most active intraday at €0.03 on 17 Feb 2026: volume spike signals short-term interest

ByDanny Kontos February 17, 2026February 17, 2026

We saw ALDEI.PA stock trade at €0.03 intraday on 17 Feb 2026 after a volume surge of 13,014,939 shares, more than double its average. The spike pushed the session range to €0.02–€0.03, attracting attention on EURONEXT for short-term traders. We cover why liquidity moved, how the biotech’s fundamentals and clinical pipeline link to price action, and what that means for traders and longer-term investors.